Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BLU

BELLUS Health (BLU) Stock Price, News & Analysis

BELLUS Health logo

About BELLUS Health Stock (NASDAQ:BLU)

Advanced Chart

Key Stats

Today's Range
$14.74
$14.75
50-Day Range
$14.42
$14.75
52-Week Range
$6.38
$14.76
Volume
3.45 million shs
Average Volume
3.08 million shs
Market Capitalization
$1.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLU Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

BLU Stock Analysis - Frequently Asked Questions

BELLUS Health Inc. (NASDAQ:BLU) issued its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.07. BELLUS Health had a negative net margin of 578,586.63% and a negative trailing twelve-month return on equity of 24.27%.

Based on aggregate information from My MarketBeat watchlists, some other companies that BELLUS Health investors own include NIO (NIO), Meta Platforms (META), Pfizer (PFE), Sorrento Therapeutics (SRNE), Alibaba Group (BABA), Tesla (TSLA) and Ford Motor (F).

Company Calendar

Last Earnings
11/10/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:BLU
CIK
1259942
Employees
74
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$76.08 million
Net Margins
-578,586.63%
Pretax Margin
-578,226.56%
Return on Equity
-24.27%
Return on Assets
-23.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
33.42
Quick Ratio
33.42

Sales & Book Value

Annual Sales
$15 thousand
Price / Sales
124,613.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.09 per share
Price / Book
4.77

Miscellaneous

Outstanding Shares
126,812,000
Free Float
96,162,000
Market Cap
$1.87 billion
Optionable
Not Optionable
Beta
0.19
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BLU) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners